Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Tracey Dawes at Reed Talent Solutions and Alison Watson from Arden University, reveal their perspectives on the impact of COVID-19 on digital transformation.
According to data collected during the first and second wave in the UK, women living in domestic abuse conditions were more likely to catch COVID - during globally observed "increased rates of violence".
Ann Matthysse, Department of Biology, University of North Carolina, explores what exactly a virus is, with a specific focus on RNA viruses and SARS-CoV-2.
Research by Augusta University, published in Vaccines, found that housing insecurity is connected to vaccine hesitancy in Black communities - especially when it comes to the younger population.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska explores the challenges and benefits of telemedicine following the COVID-19 pandemic.
The pandemic has increased demand for single-use plastics such as face masks, gloves, and face shields – so what happens to COVID-related plastic waste?
Here, Open Access Government interview Dr Babita Agrawal, Professor in the Department of Surgery, University of Alberta to discuss the continued need for research into vaccines and immunotherapeutics.
Akash Gupta, Co-founder and CTO, GreyOrange, explores how AI can help solve the UK's supply chain crisis as a result of lorry driver shortages, caused by Brexit and the pandemic.
